| abstract |
A formulation for the treatment of degenerative spinal disc disease, comprising: (a) autologous autologous mesenchymal stem cells, and (b) growth differentiation factor (GDF-5), in which the formulation is suitable for administered on a degenerating disc immediately after collecting the cells, the formulation being administered as a suspension containing the autologous autologous stem cells that have been concentrated after harvesting and the growth differentiation factor 5 in a growth medium or vehicle in one volume between 0.5 ml and 3.0 ml. |